Nicox SA, an international ophthalmology company, announced a poster presentation highlighting responder analyses results from the Dolomites Phase 2 clinical trial on NCX 470 in patients with open-angle glaucoma or ocular hypertension at the American Academy of Ophthalmology 2021Annual Meeting being held from November 12-15, 2021 in New Orleans, LA, U.S.
November 10, 2021
· 3 min read